Clinical trial Recruiting at 1 site Observational Ages 7 to 18

Long-term follow-up of children exposed to trauma

Official title: Trauma-Exposed Children and Adolescents: A One-Year Follow-Up Study

Run by Istanbul University · NCT06975852 · Data updated 2026-11-12

This study looks at children and teens who experienced trauma to see how many still have PTSD or develop new symptoms a year later, while also translating a trauma screening tool into Turkish.

More Post-traumatic Stress Disorder (PTSD) trials

Quick facts

Study typeObservational
Ages7 Years to 18 Years
SexAll
Enrollment210 (estimated)
SponsorIstanbul University
Academic / other
Locations1 site (Istanbul, Fatih)
StatusRecruiting
StartedFebruary 17, 2025
Main results expectedJuly 18, 2025
Study endsAugust 15, 2025
Registry record updatedMay 16, 2025
Trial IDNCT06975852 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and adolescents aged 7-18 who have been exposed to at least one traumatic event and were evaluated in the previous year.

Probably not a fit

Patients with psychotic/manic symptoms, autism spectrum disorder, or intellectual disabilities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to reassess children and adolescents aged 7-18 who were previously evaluated for trauma exposure at the Istanbul Faculty of Medicine Child Psychiatry outpatient clinic. The study will investigate how many of these individuals continue to meet the criteria for Post-Traumatic Stress Disorder (PTSD) or are diagnosed with Complex Post-Traumatic Stress Disorder (CPTSD) one year later. Additionally, it seeks to translate the Child and Adolescent Trauma Screen Scale - 2 (CATS-2) into Turkish and evaluate its psychometric properties, contributing to the understanding of long-term trauma effects in this population.

Why it matters

Potential benefit: If successful, this study could enhance the understanding and treatment of PTSD and CPTSD in children and adolescents, leading to better therapeutic strategies.

How similar studies have gone: While this study is novel in Turkey, similar longitudinal studies in other countries have shown success in understanding the long-term effects of trauma on children.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study one year ago (January-April 2024),
* Children and adolescents aged 7-18,
* Children and/or parents with adequate literacy and Turkish language skills.

Exclusion Criteria:

* The presence of psychotic/manic symptoms in the child or parent during the interview or any condition that makes the interview and assessment impossible (e.g., mental or developmental condition or a different communication language),
* The child or parent refusing to participate in the study,
* The presence of autism spectrum disorder or intellectual disability at a severity that prevents assessment.

Where it's running

  • Istanbul Faculty of Medicine
    Istanbul, Fatih, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Abdurrahman C Orengul, Associate Professor — Istanbul Faculty of Medicine, Child and Adolescent Psychiatry Department
  • Study coordinator: Beyza N Karal, MD
  • Email: beyzakaral@istanbul.edu.tr
  • Phone: +9002124142000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.